Some people are losing too much weight in Retatrutide trial.

Randomized trial results of the experimental GLP-1, GIP, and glucagon drug shows that it may be too effective, while causing a whopping 11% of participants at the highest dose to drop out because of the severity of the side effects. In Optimizer, Victoria Song covered TikTok influencers pushing grey market knockoffs of “Ratatouille” and attempted to find out what was actually in them. (Please don’t buy shady “Retatrutide” from the internet.) Posts from this author will be added to your daily email digest and your homepage feed. Posts from this topic will be added to your daily email digest and your homepage feed. Posts from this topic will be added to your daily email digest and your homepage feed. Posts from this topic will be added to your daily email digest and your homepage feed. Posts from this topic will be added to your daily email digest and your homepage feed. Posts from this topic will be added to your daily email digest and your homepage feed. A free daily digest of the news that matters most. The Verge is a part of PMX Global, LLC, a subsidiary of Penske Media Corporation. © 2026 VM Publishing, LLC. All rights reserved. Sign in to see your notifications or create an acc
Source: For the complete article, please visit the original source link below.





